12:00 AM
 | 
Dec 14, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Folotyn pralatrexate regulatory update

Allos launched the international COMPLETE observational registry to evaluate longitudinal treatment patterns and outcomes in patients with newly-diagnosed PTCL. The study will...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >